Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: FDA Approves Imaavy for wAIHA
FDA approves Imaavy as the first treatment for warm autoimmune hemolytic anemia, McKesson agrees to acquire Precision Medicine Group as Lundbeck part…
2 months, 3 weeks ago
Pharmaceutical Executive Daily: Hanmi Licenses HM17321 to Genentech
Hanmi Pharm licenses its obesity drug candidate HM17321 to Genentech, James LaValle weighs in after FDA advisors back most nominated peptides for the…
2 months, 3 weeks ago
Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly
Amplitude Therapeutics and Chai Discovery ink AI and RNA collaborations with Eli Lilly and Bristol Myers Squibb, Norstella's Dan Chancellor makes the…
2 months, 4 weeks ago
Pharmaceutical Executive Daily: FDA Approves Pasatru
A partnership roundup covers deals from IntraGel Therapeutics/UroGen Pharma and Lupin/Tenpoint Therapeutics, FDA approves Regeneron's Pasatru for fib…
2 months, 4 weeks ago
Pharmaceutical Executive Daily: President Trump to Nominate Heidi Overton as FDA Commissioner
President Trump moves to nominate Heidi Overton as FDA commissioner, Ron Lanton weighs in on drug pricing's collision with trade policy, and Mohd Haq…
2 months, 4 weeks ago
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
LEO Pharma, BioMarin, OmniAb, and Chugai post a busy week of pharma dealmaking, RELEX's Rohit Tripathi weighs in on who ultimately pays for tariff-dr…
3 months ago
Pharmaceutical Executive Daily: Henlius and Sandoz Strike Collaboration Agreement
Henlius and Sandoz ink a biosimilars collaboration, ADVI's Tyler Seville makes the case for 340B reform, and RELEX's Rohit Tripathi weighs in on what…
3 months ago
Pharmaceutical Executive Daily: Pharm Exec Ranks Top 50 Companies of 2026
Pharmaceutical Executive releases its 2026 Top 50 company rankings, FDA grants Bristol Myers Squibb's Zenbexus accelerated approval for multiple myel…
3 months ago
Pharmaceutical Executive Daily: 2026 Emerging Pharma Leaders Award Winners Announced
A funding roundup covers new IPO and Series A raises across Silence Therapeutics, AbCellera, Beyang Therapeutics, and Remepy, Tyler Seville of ADVI e…
3 months ago
Pharmaceutical Executive Daily: Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics
Mereo BioPharma licenses its lung disease treatment alvelestat to Sentynl Therapeutics, Krieger Scientific's Joseph Morwald examines what's driving a…
3 months ago